Eli Lilly and Co (LLY)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$1,150.73

Buy

$1,151.78

arrow-down$-1.02 (-0.09%)

Prices updated at 15 Jul 2026, 18:58 EDT

Prices minimum 15 mins delay

Prices in USD

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic ...

S&P 500

0.34%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$1,152.49 - $1,134.40
	$1,249.45 - $623.78
	0.58
	1,027,767.64m
	40.94
	-
	1,178,743
	32.94
	3,708,946.52
	0.38
	944.80m
	US5324571083
	28.15
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.